infection

Tim Draper leads $6M Series A in pee-testing wellness tracker, Vivoo

Billionaire VC Tim Draper (via Draper Associates) has led a $6 million Series A in wellness tracking startup, Vivoo. Also participating in the funding round is ONCE Ventures, Revo Capital, 500 Startup

Mobile dialysis startup eyes human trials in 2022 following encouraging animal study

This past year, three sheep in Canada have been wearing their kidneys on their sleeves. Or more aptly, in jackets on their fluffy backs.  These three sheep are part of an ongoing animal study run by

How Rani Therapeutics’ robotic pill could change subcutaneous injection treatment

A new auto-injecting pill might soon become a replacement for subcutaneous injection treatments. The idea for this so-called robotic pill came out of a research project around eight years ago from InC

Moderna’s 30,000-participant Phase 3 COVID-19 vaccine trial kicks off in the US

The largest trial yet for a potential COVID-19 vaccine began on Monday, as drug company Moderna began providing the first of an anticipated 30,000 volunteers with shots of its candidates. This is a bl

FDA revokes emergency authorization for chloroquine and hydroxychloroquine in COVID-19 treatment

The U.S. Food and Drug Administration (FDA) has revoked an emergency use authorization (EUA) that it previously issued for chloroquine and hydroxychloroquine, two anti-malarial drugs also used in the

Apple adds anonymous symptom and health info sharing to its COVID-19 app and website

Apple has updated its own COVID-19 iOS app and website with new features to allow users to anonymously share info, including their age, number of existing health conditions, symptoms, potential exposu

Researchers use biometrics, including data from the Oura Ring, to predict COVID-19 symptoms in advance

A team of researchers from the West Virginia University (WVU) Rockefeller Neuroscience Institute (RNI), along with WVU’s Medicine department and staff from Oura Health have developed a platform

Sorrento finds a coronavirus antibody that blocks viral infection 100% in preclinical lab experiments

Therapeutics company Sorrento has made what it believes could be a breakthrough in potential treatment of SARS-CoV-2, the virus that leads to COVID-19. The company released details of its preclinical

GreenLight Biosciences raises $17M to ramp mRNA production for COVID-19 vaccine candidate trials

One of the approaches therapeutics companies are taking to developing vaccines for COVID-19 relies on what’s called an mRNA (messenger RNA, which essentially provides cells with protein producti

NWU researchers develop a throat-worn wearable that could offer early warnings for COVID-19 patients

The ongoing COVID-19 pandemic is resulting in big shifts across industries, but the development of more long-term solutions that address a future in which what we need to do is mitigate the impact of

LabCorp’s at-home COVID-19 test kit is the first to be authorized by the FDA

LabCorp’s at-home COVID-19 test, which is called ‘Pixel,’ has received the first Emergency Use Authorization (EUA) for such a test issued by the U.S. Food and Drug Administration (FD

3D-printed glasses startup Fitz is making custom protective eyewear for healthcare workers

A lot of startups have answered the call for more personal protective equipment (PPE) and other essentials to support healthcare workers in their efforts to curb the spread and impact of COVID-19. One

LA COVID-19 antibody study adds further support for a higher-than-suspected infection rate

A new study conducted by the University of Southern California along with the LA County Department of Public Health indicates the presence of antibodies for COVID-19 in between 2.8 and 5.6% of the pop

Curative received FDA emergency use authorization for its novel COVID-19 tests

The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection. The company says that its tests h

University of Oxford coronavirus vaccine trial aims to have 500 people in testing by mid-May

One of the largest COVID-19 vaccine trials currently underway will have over 500 volunteers actively testing its solution by the middle of next month. Researchers at the University of Oxford have alre

New MIT machine learning model shows relaxing quarantine rules will spike COVID-19 cases

MIT has developed a new model of the spread of COVID-19 infection, based on publicly available data, combined with established epidemiological equations about outbreaks, and neural network-based infer

Using AI, Yes Health cuts costs, improves adherence for weight loss and diabetes treatment

Using a combination of machine learning and computer vision, Yes Health claims it can cut costs and improve adherence for behavioral-based treatments targeting diabetes, obesity and other chronic cond

Scanwell begins 1,000 person study for at-home antibody test for COVID-19

At-home antibody testing for COVID-19 is the subject of ample debate among the scientific and medical community, with some seeing it as a necessary step in the process of selectively re-opening parts

Potential new treatment for COVID-19 uncovered by BenevolentAI enters trials

BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as a potential treatment for COVID-19, after it applied i

Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19

Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on
Load More